25th Jun 2025 14:30
(Alliance News) - BSF Enterprise PLC on Wednesday announced a narrowed loss as it remains dedicated to advancing its portfolio, which focuses on sustainable tissue-engineered materials.
The London-based biotech company is the owner of companies including 3D Bio-Tissues, a pioneer of lab-grown tissues, as well as the corneal replacement company Kerato.
The company said pretax loss narrowed to GBP793,963 in the six months to March 31, from GBP864,775 a year prior.
Revenue fell 62% to GBP20,559 from GBP54,295. Grant income jumped to GBP67,823 from GBP3,779.
Cost of sales came down 81% to GBP5,065 from GBP25,997.
Looking ahead, BSF Enterprise said: "BSF Enterprise remains dedicated to advancing its portfolio of sustainable tissue-engineered materials and strategic collaborations. With significant progress in lab-grown leather commercialisation, partnerships with industry leaders, and successful financing initiatives completed in 2025, the group is well-positioned for continued growth, innovation, and value creation in the year ahead."
BSF Enterprise shares were 0.7% higher at 2.27 pence each on Wednesday afternoon in London.
By Tom Budszus, Alliance News slot editor
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Related Shares:
Bio-Sustainable Future Enterprises